Lipids can be unpredictable and unstable. Croda has acquired Avanti for an initial consideration of $185m on a debt and cash-free basis, with an additional earnout of up to $75m based on near-term commercial opportunities using Avanti’s lipid-based solutions. Avanti creates and makes high-purity polar lipids that are increasingly being used as delivery systems for complex therapeutic drugs and in next-generation mRNA vaccines. Avanti ® Polar Lipids: Pure Expertise in Lipids Research Products. These lipid technologies ensure the targeted, controlled and extended release of active pharmaceutical ingredients (APIs), increasing their efficacy and safety. The Avanti ® team has consistently led the industry to create pure lipids, winning many awards along the way. About Avanti Polar Lipids. ALABASTER, Alabama, July 6, 2020 /PRNewswire/ -- Avanti Polar Lipids, Inc. ("Avanti" or the "Company") today announces it has agreed to be acquired by Croda International Plc ("Croda").
At Avanti Polar Lipids, we offer a creative and professional environment where people succeed. Alabaster-based Avanti Polar Lipids Inc., will be acquired by Croda International Plc., a United Kingdom-based life sciences company. The acquisition is being financed by a three-year term loan, Croda said.
of Avanti® Polar Lipids to customers outside the United States. Croda International Plc has agreed to acquire Avanti Polar Lipids, Inc. for an initial consideration of $185 million on a debt and cash-free basis, with an additional earnout of up to $75 million based on near-term commercial opportunities using Avanti's lipid-based solutions. The business provides its world-class products and … ALABASTER, Alabama, July 6, 2020 /PRNewswire/ -- Avanti Polar Lipids, Inc. ("Avanti" or the "Company") today announces it has agreed to be acquired by Croda International Plc ("Croda"). We’ve partnered with Avanti ® Polar Lipids to make high-purity lipids more accessible to researchers around the world. Our process looks like this: We hire smart, passionate people, give them the tools they need to succeed, and then get out of their way!
Our team members care a lot about what they do every day, which is how we’re able to produce such high quality products. Lipids can be unpredictable and unstable. These advanced lipidomics, adjuvants, and equipment products will still be produced by the Avanti ® Polar Lipids company and have the Avanti ® name.
We are the exclusive provider of Avanti ® Polar Lipids research products for all countries except the United States. Croda International has agreed to acquire Avanti Polar Lipids, a company providing lipid-based drug delivery technologies for next generation pharmaceuticals. You don’t need to be a lipid specialist to know that you should order from one. Choose Avanti ® products and stop inferior lipids from jeopardizing your experiments. Avanti Polar Lipids, Inc. ("Avanti" or the "Company") today announces it has agreed to be acquired by Croda International Plc ("Croda").
Financial terms of the deal were not disclosed. You don’t have to be a lipid specialist when you order from someone who is. Avanti specializes in the development and production of high-purity polar lipids that are increasingly being used in next-generation drug delivery technology and vaccines. About Avanti Polar Lipids, Inc.: More at: www.avantilipids.com. Alabaster-based Avanti Polar Lipids Inc., will be acquired by Croda International Plc., a United Kingdom-based life sciences company. Financial terms of the deal were not disclosed.
Avanti ® Polar Lipids Now Exclusively Available from MilliporeSigma* 2 Whether you specialize in lipidomics or lipids are simply a part of your research, you know the critical role lipids play and the inherent challenges they present. With the vast library of Avanti lipids and state-of-the-art equipment at their disposal, our experienced team can produce surface-labeled, PEGylated, fluorescent, and other liposome formulations, while working closely with our Lipid Analysts to ensure Avanti quality.
Mini-Extruder for Efficient Lipid Extrusion from Avanti® Polar Lipids.
More at: www.avantilipids.com Founded in 1967 by Dr. Walter and Rowena Shaw, Avanti specializes in the development and production of high-purity polar lipids that are used in next-generation drug delivery technology and mRNA vaccines. ALABASTER, Alabama, July 6, 2020 /PRNewswire/ -- Avanti Polar Lipids, Inc. ("Avanti" or the "Company") today announces it has agreed to be acquired by Croda International Plc ("Croda"). We’ve partnered with Avanti ® Polar Lipids to make high-purity lipids more accessible to researchers around the world.